Karolina Iwanicka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Karolina Iwanicka has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Karolina Pawelec
Chair and Department of Anatomy, Medical University of Lublin, Poland
5 shared publications - Jakub Jagiełło
Military Institute of Medicine – National Research Institute, Warsaw, Poland
4 shared publications - Laura Maria Surdacka-Barańska
1st Military Clinical Hospital with Polyclinic in Lublin, Independent Public Healthcare Institution, Lublin, Poland
4 shared publications - Mateusz Kaczmarski
STUDENT SCIENTIFIC ASSOCIATION OF THE LABORATORY OF LOCOMOTOR SYSTEMS RESEARCH, MEDICAL UNIVERSITY OF LUBLIN, LUBLIN, POLAND
4 shared publications - Sabina Jóźwiak
Chair and Department of Anatomy, Medical University of Lublin, Poland
4 shared publications - Adam Jakubas
Bielański Hospital in Warsaw, Cegłowska 80, 01-809 Warszawa, Poland
3 shared publications
Latest Publications
- 19 October 2026
- Published by Medical Communications Sp. z.o.o. in Pediatria i Medycyna Rodzinna
- Vol. 22 (3) , 180
Acute pancreatitis as an initial manifestation of primary hyperparathyroidism: a case report
Acute pancreatitis is one of the most common gastroenterological diseases. The diagnosis of acute pancreatitis requires the presence of at least two of the following criteria: a typical clinical presentation, serum lipase and/or amylase levels exceeding three times the upper limit of normal, or imaging studies characteristic of acute pancreatitis. Numerous conditions may contribute to the development of acute pancreatitis, the most common being chronic alcohol abuse and cholelithiasis (gallstones). Rare causes of acute pancreatitis include, among others, hypercalcaemia. This article presents the case of a woman with recurrent episodes of acute pancreatitis caused by hypercalcaemia (peak serum calcium level: 13.3 mg/dL; peak serum parathyroid hormone level: 416 pg/mL), who was ultimately diagnosed with a parathyroid adenoma. The diagnostic workup and treatment are also described. Appropriate management of patients with acute pancreatitis requires an understanding of the disease aetiology.
- 19 October 2026
- Published by Medical Communications Sp. z.o.o. in Pediatria i Medycyna Rodzinna
- Vol. 22 (3) , 180
Acute pancreatitis as an initial manifestation of primary hyperparathyroidism: a case report
Acute pancreatitis is one of the most common gastroenterological diseases. The diagnosis of acute pancreatitis requires the presence of at least two of the following criteria: a typical clinical presentation, serum lipase and/or amylase levels exceeding three times the upper limit of normal, or imaging studies characteristic of acute pancreatitis. Numerous conditions may contribute to the development of acute pancreatitis, the most common being chronic alcohol abuse and cholelithiasis (gallstones). Rare causes of acute pancreatitis include, among others, hypercalcaemia. This article presents the case of a woman with recurrent episodes of acute pancreatitis caused by hypercalcaemia (peak serum calcium level: 13.3 mg/dL; peak serum parathyroid hormone level: 416 pg/mL), who was ultimately diagnosed with a parathyroid adenoma. The diagnostic workup and treatment are also described. Appropriate management of patients with acute pancreatitis requires an understanding of the disease aetiology.
- Open Access
- 14 July 2026
- Published by Our Dermatology Online in Our Dermatology Online
- Vol. 17 (e) , e26
Modern approaches to the treatment of atopic dermatitis in children: The role of biologics and Janus kinase inhibitors
Atopic dermatitis (AD) is a chronic, inflammatory skin disease that often begins in early childhood and significantly affects the quality of life of patients and their families. Conventional treatments include emollients, corticosteroids, and calcineurin inhibitors; however, these are often insufficient in moderate-to-severe cases. In recent years, novel targeted therapies, including biologics and Janus kinase (JAK) inhibitors, have shown promising clinical results in pediatric patients. Dupilumab and tralokinumab, monoclonal antibodies, have demonstrated significant improvement in AD symptoms, including reduction of pruritus and inflammation. JAK inhibitors, such as upadacitinib, abrocitinib, and baricitinib, modulate cytokine pathways involved in AD pathogenesis, leading to rapid and sustained improvement of skin lesions. These novel therapies exhibit favorable safety profiles and enable personalized approaches. This article reviews current evidence on the efficacy and safety of dupilumab, tralokinumab, and JAK inhibitors in the pediatric population, highlighting their role in modern AD management.
- 14 July 2026
- Published by Our Dermatology Online in Our Dermatology Online
- Vol. 17 (e) , e26
Open AccessModern approaches to the treatment of atopic dermatitis in children: The role of biologics and Janus kinase inhibitors
Atopic dermatitis (AD) is a chronic, inflammatory skin disease that often begins in early childhood and significantly affects the quality of life of patients and their families. Conventional treatments include emollients, corticosteroids, and calcineurin inhibitors; however, these are often insufficient in moderate-to-severe cases. In recent years, novel targeted therapies, including biologics and Janus kinase (JAK) inhibitors, have shown promising clinical results in pediatric patients. Dupilumab and tralokinumab, monoclonal antibodies, have demonstrated significant improvement in AD symptoms, including reduction of pruritus and inflammation. JAK inhibitors, such as upadacitinib, abrocitinib, and baricitinib, modulate cytokine pathways involved in AD pathogenesis, leading to rapid and sustained improvement of skin lesions. These novel therapies exhibit favorable safety profiles and enable personalized approaches. This article reviews current evidence on the efficacy and safety of dupilumab, tralokinumab, and JAK inhibitors in the pediatric population, highlighting their role in modern AD management.
- Open Access
- 9 July 2026
- Published by Medical Communications Sp. z.o.o. in Pediatria i Medycyna Rodzinna
- Vol. 22 (2) , 114
Melkersson–Rosenthal syndrome in a child – a rare diagnostic challenge. Case report
Facial nerve palsy has a heterogeneous aetiology. One of the rare causes of recurrent seventh cranial nerve palsy is Melkersson–Rosenthal syndrome, which is diagnosed primarily on the basis of its characteristic clinical presentation. This paper presents the case of a 17-year-old female patient hospitalised with right-sided peripheral facial nerve palsy. Physical examination, in addition to features of seventh cranial nerve palsy, revealed characteristic fissuring of the tongue. The medical history further indicated a previous episode of contralateral facial nerve palsy and recurrent self-limiting episodes of facial oedema. Extended laboratory and imaging diagnostics excluded infectious, neoplastic, autoimmune, and traumatic aetiologies. Based on the fulfilment of the diagnostic criteria, Melkersson–Rosenthal syndrome was diagnosed. Systemic glucocorticosteroid therapy, supportive treatment, and intensive rehabilitation were initiated, resulting in partial improvement in neurological status.
- 9 July 2026
- Published by Medical Communications Sp. z.o.o. in Pediatria i Medycyna Rodzinna
- Vol. 22 (2) , 114
Open AccessMelkersson–Rosenthal syndrome in a child – a rare diagnostic challenge. Case report
Facial nerve palsy has a heterogeneous aetiology. One of the rare causes of recurrent seventh cranial nerve palsy is Melkersson–Rosenthal syndrome, which is diagnosed primarily on the basis of its characteristic clinical presentation. This paper presents the case of a 17-year-old female patient hospitalised with right-sided peripheral facial nerve palsy. Physical examination, in addition to features of seventh cranial nerve palsy, revealed characteristic fissuring of the tongue. The medical history further indicated a previous episode of contralateral facial nerve palsy and recurrent self-limiting episodes of facial oedema. Extended laboratory and imaging diagnostics excluded infectious, neoplastic, autoimmune, and traumatic aetiologies. Based on the fulfilment of the diagnostic criteria, Melkersson–Rosenthal syndrome was diagnosed. Systemic glucocorticosteroid therapy, supportive treatment, and intensive rehabilitation were initiated, resulting in partial improvement in neurological status.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
DIGITAL TECHNOLOGIES IN DIABETES MANAGEMENT: THE ROLE OF CONTINUOUS GLUCOSE MONITORING AND ARTIFICIAL INTELLIGENCE IN MODERN ENDOCRINOLOGY
The ongoing development of digital technologies, when used appropriately in diabetes care, has a significant impact on the management of patients with diabetes. New technologies enable the monitoring and adjustment of treatment in patients without the need for face-to-face appointments. The aim of this review is to discuss the role of continuous glucose monitoring, artificial intelligence, wearables, mobile applications and telemedicine in the development of diabetes care. Their clinical, organisational and social significance has been analysed. This is a review article based on publications from major biomedical databases.Reviewed articles provide evidence that continuous glucose monitoring is more accurate for assessing blood glucose levels than traditional glucose or HbA1c measurements. Artificial intelligence can be used to predict fluctuations in blood glucose levels and improve the personalization of clinical decisions. It has been shown to be particularly effective when combined with automated insulin delivery systems. Mobile devices and apps, as well as telemedicine, can increase patients’ interest in their own health and, consequently, their involvement in the treatment process; however, their value depends on the quality of the collected data, interoperability, clinical usability, and the ability of healthcare professionals to understand the generated reports. The use of digital tools is associated with cyber threats regarding data privacy, as well as inequalities in access to healthcare and trust in technology among patients. Future research should cover long-term effectiveness, safety, equitable access, and the methods of implementing this technology into everyday patient care.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessDIGITAL TECHNOLOGIES IN DIABETES MANAGEMENT: THE ROLE OF CONTINUOUS GLUCOSE MONITORING AND ARTIFICIAL INTELLIGENCE IN MODERN ENDOCRINOLOGY
The ongoing development of digital technologies, when used appropriately in diabetes care, has a significant impact on the management of patients with diabetes. New technologies enable the monitoring and adjustment of treatment in patients without the need for face-to-face appointments. The aim of this review is to discuss the role of continuous glucose monitoring, artificial intelligence, wearables, mobile applications and telemedicine in the development of diabetes care. Their clinical, organisational and social significance has been analysed. This is a review article based on publications from major biomedical databases.Reviewed articles provide evidence that continuous glucose monitoring is more accurate for assessing blood glucose levels than traditional glucose or HbA1c measurements. Artificial intelligence can be used to predict fluctuations in blood glucose levels and improve the personalization of clinical decisions. It has been shown to be particularly effective when combined with automated insulin delivery systems. Mobile devices and apps, as well as telemedicine, can increase patients’ interest in their own health and, consequently, their involvement in the treatment process; however, their value depends on the quality of the collected data, interoperability, clinical usability, and the ability of healthcare professionals to understand the generated reports. The use of digital tools is associated with cyber threats regarding data privacy, as well as inequalities in access to healthcare and trust in technology among patients. Future research should cover long-term effectiveness, safety, equitable access, and the methods of implementing this technology into everyday patient care.
- Open Access
- 15 June 2026
- Published by Uniwersytet Warminsko-Mazurski in Polish Annals of Medicine
- Vol. 33, 197-202
Refusal of hospital admission and discharge against medical advice in children and adolescents: A retrospective study in the Independent Public Provincial Specialist Hospital in Chełm, 2013–2018
Introduction: Refusal of hospitalisation and DAMA in paediatric patients are insufficiently studied, especially in Poland and Central and Eastern Europe. These decisions may affect safety and care continuity and are shaped by medical and non-medical factors. Aim: To analyse the frequency, circumstances, and selected determinants of refusal of hospitalisation and DAMA among patients in the Pediatric Ward of the Independent Public Provincial Specialist Hospital in Chełm in 2013–2018. Material and methods: This retrospective study analysed medical records of patients under 18 years of age presenting to the Emergency Department, Admission Rooms, and Pediatric Ward. Patients recorded during the first 10 days of each month in 2013–2018 were included. Variables were age, sex, ICD-10 diagnosis, mode of admission, length of stay, and discharge type. Analysis used Microsoft Excel and R 4.0.5, with α = 0.05. Results and discussion: Among 6,525 analysed cases, refusal of hospitalisation occurred in 4.9% (n = 320). Among 2,315 hospitalised patients, discharge at the request of a legal guardian occurred in 11.4% (n = 263). DAMA patients were more often admitted by Emergency Medical Services than all cases (46.6% vs. 21.5%). Gastrointestinal disorders and infections were the most common diagnoses. Conclusions: Refusal of admission and DAMA were not rare in this paediatric population. Further prospective studies are needed to identify causes and support interventions aimed at reducing these events.
- 15 June 2026
- Published by Uniwersytet Warminsko-Mazurski in Polish Annals of Medicine
- Vol. 33, 197-202
Open AccessRefusal of hospital admission and discharge against medical advice in children and adolescents: A retrospective study in the Independent Public Provincial Specialist Hospital in Chełm, 2013–2018
Introduction: Refusal of hospitalisation and DAMA in paediatric patients are insufficiently studied, especially in Poland and Central and Eastern Europe. These decisions may affect safety and care continuity and are shaped by medical and non-medical factors. Aim: To analyse the frequency, circumstances, and selected determinants of refusal of hospitalisation and DAMA among patients in the Pediatric Ward of the Independent Public Provincial Specialist Hospital in Chełm in 2013–2018. Material and methods: This retrospective study analysed medical records of patients under 18 years of age presenting to the Emergency Department, Admission Rooms, and Pediatric Ward. Patients recorded during the first 10 days of each month in 2013–2018 were included. Variables were age, sex, ICD-10 diagnosis, mode of admission, length of stay, and discharge type. Analysis used Microsoft Excel and R 4.0.5, with α = 0.05. Results and discussion: Among 6,525 analysed cases, refusal of hospitalisation occurred in 4.9% (n = 320). Among 2,315 hospitalised patients, discharge at the request of a legal guardian occurred in 11.4% (n = 263). DAMA patients were more often admitted by Emergency Medical Services than all cases (46.6% vs. 21.5%). Gastrointestinal disorders and infections were the most common diagnoses. Conclusions: Refusal of admission and DAMA were not rare in this paediatric population. Further prospective studies are needed to identify causes and support interventions aimed at reducing these events.
- Open Access
- 31 December 2025
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
- Vol. 19 (4) , 164-168
Strike in a stroke– a unique case of highly successful treatment of a paediatric patient
Introduction. Stroke is a rare condition in children, affecting 1-2 per 100 paediatric patients annually. Despite the low incidence, it is the leading cause of neurological disorders in this age group. Case Report. An 8-year-old girl was admitted to the emergency department with reduced muscle strength, drooping of the left corner of the mouth, and sensory disturbances. Imaging studies revealed intracerebral haemorrhagic foci surrounded by oedema in the right frontal lobe, subarachnoid haemorrhagic foci, as well as ischemic changes in the left frontal lobe. Empiric pharmacotherapy with anti-coagulants, anti-oedematous agents and antibiotics was applied. After treatment and rehabilitation, substantial improvement was observed. Conclusions. Management of strokes in paediatric patients poses significant challenges. Absence of well-established guidelines and randomized clinical trials in this age group often necessitates empiric therapy, which proved to be highly effective in the presented case.
- 31 December 2025
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
- Vol. 19 (4) , 164-168
Open AccessStrike in a stroke– a unique case of highly successful treatment of a paediatric patient
Introduction. Stroke is a rare condition in children, affecting 1-2 per 100 paediatric patients annually. Despite the low incidence, it is the leading cause of neurological disorders in this age group. Case Report. An 8-year-old girl was admitted to the emergency department with reduced muscle strength, drooping of the left corner of the mouth, and sensory disturbances. Imaging studies revealed intracerebral haemorrhagic foci surrounded by oedema in the right frontal lobe, subarachnoid haemorrhagic foci, as well as ischemic changes in the left frontal lobe. Empiric pharmacotherapy with anti-coagulants, anti-oedematous agents and antibiotics was applied. After treatment and rehabilitation, substantial improvement was observed. Conclusions. Management of strokes in paediatric patients poses significant challenges. Absence of well-established guidelines and randomized clinical trials in this age group often necessitates empiric therapy, which proved to be highly effective in the presented case.
- Open Access
- 22 December 2025
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 39 (1) , 59-66
Topical medicines in chemotherapy-induced peripheral neuropathy
Oncology patients face numerous challenges resulting both from their underlying disease and from the adverse effects of anticancer treatment. Chemotherapy-induced peripheral neuropathy (CIPN) is among the most serious complications associated with chemotherapy. The sensory and motor disturbances observed in the course of CIPN are often progressive and may be irreversible, while severe and chronic pain leads to a substantial reduction in patients’ quality of life (QoL). This narrative review summarizes currently available topical treatment options for CIPN, focusing on substances that have shown potential clinical benefit. The pathogenesis of CIPN remains incompletely understood, and existing treatment strategies are frequently insufficient or associated with significant adverse effects. Consequently, both the prevention and management of CIPN remain important challenges in contemporary medicine. Recently, increasing attention has been directed toward topically administered agents, including formulations based on phenytoin, lidocaine, amitriptyline, capsaicin, cannabinoids, duloxetine, ketamine, and baclofen. These therapies may alleviate neuropathic symptoms and improve QoL without the systemic complications commonly associated with oral or intravenous pharmacotherapy. The use of topical medications may also allow for a reduction in systemic analgesic doses and is often favored due to their more favorable safety profile. Therefore, topical agents should be considered promising therapeutic options aimed at minimizing systemic side effects and optimizing the current pharmacological management of patients with CIPN.
- 22 December 2025
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 39 (1) , 59-66
Open AccessTopical medicines in chemotherapy-induced peripheral neuropathy
Oncology patients face numerous challenges resulting both from their underlying disease and from the adverse effects of anticancer treatment. Chemotherapy-induced peripheral neuropathy (CIPN) is among the most serious complications associated with chemotherapy. The sensory and motor disturbances observed in the course of CIPN are often progressive and may be irreversible, while severe and chronic pain leads to a substantial reduction in patients’ quality of life (QoL). This narrative review summarizes currently available topical treatment options for CIPN, focusing on substances that have shown potential clinical benefit. The pathogenesis of CIPN remains incompletely understood, and existing treatment strategies are frequently insufficient or associated with significant adverse effects. Consequently, both the prevention and management of CIPN remain important challenges in contemporary medicine. Recently, increasing attention has been directed toward topically administered agents, including formulations based on phenytoin, lidocaine, amitriptyline, capsaicin, cannabinoids, duloxetine, ketamine, and baclofen. These therapies may alleviate neuropathic symptoms and improve QoL without the systemic complications commonly associated with oral or intravenous pharmacotherapy. The use of topical medications may also allow for a reduction in systemic analgesic doses and is often favored due to their more favorable safety profile. Therefore, topical agents should be considered promising therapeutic options aimed at minimizing systemic side effects and optimizing the current pharmacological management of patients with CIPN.
- Open Access
- 12 May 2025
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
Clinical presentation and management of PANDAS Syndrome – Case Report
Autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) are difficult to recognize and diagnose. Symptoms are non-specific, appear suddenly, and may be related to a prior Group A beta-haemolytic streptococcal infection. Limited research complicates treatment. The...
- 12 May 2025
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
Open AccessClinical presentation and management of PANDAS Syndrome – Case Report
Autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) are difficult to recognize and diagnose. Symptoms are non-specific, appear suddenly, and may be related to a prior Group A beta-haemolytic streptococcal infection. Limited research complicates treatment. The...
- Open Access
- 2 February 2024
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
- Vol. 1 (18) , 74-82
Migraines in childhood as a cause of headache in adulthood – how to prevent it? A literature review
Introduction and objective: Migraine is the most common acute and recurrent headache in children. The pain is the result of stimulation of meningeal nociceptors. There may be a genetic predisposition to generalized neuronal hyperexcitability. Aura is caused by the cortical spreading depression...
- 2 February 2024
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
- Vol. 1 (18) , 74-82
Open AccessMigraines in childhood as a cause of headache in adulthood – how to prevent it? A literature review
Introduction and objective: Migraine is the most common acute and recurrent headache in children. The pain is the result of stimulation of meningeal nociceptors. There may be a genetic predisposition to generalized neuronal hyperexcitability. Aura is caused by the cortical spreading depression...
- Open Access
- 1 March 2022
- Published by Medical University of Lublin in Current Problems of Psychiatry
- Vol. 23 (1) , 35-40
Schizo-obsessive disorder - case study
Introduction: Schizo-obsessive disorder is a term that includes a dual diagnosis: schizophrenia and obsessive-compulsive disorder (OCD). The schizo-obsessive disorder definition was made at the end of the 19th century and is still valid today. Nowadays, the coexistence of schizophrenia with obsessive-compulsive syndromes becomes more commonly observed, therefore the recognition and number of the described cases has increased. Material and methods: The aim of this article is to present a clinical case of a patient with a diagnostically and therapeutically difficult disorder, including the comorbidity of schizophrenia and OCD. The analysis of the clinical case and the medical records of a patient and a review of the literature including schizophrenia, OCD, and schizo-obsessive disorder, was performed. Case study: A male patient, 20 years old, single, high school student, who lives with his family. In November 2019 a mental deterioration occurred. Simultaneously, obsessional ideas and behaviors appeared. An ambulatory treatment was introduced, however without adequate response, which was the cause of the first psychiatric hospitalization in 2020. Discussion: Comorbidity between obsessive-compulsive disorder and schizophrenia may cause a particular problem for physicians. Without appropriate diagnosis, there is no possibility to implement proper management and treatment. Obsessive-compulsive symptoms should be treated as relatively common in patients with schizophrenia, which will prevent a mistake in the assessment of the patient’s condition. Conclusions: Due to specific character of the disease, difficulties in diagnosis and treatment, there is a special need for individual therapeutic measures. Appropriate and targeted approach to the patient may be a chance for success in therapy.
- 1 March 2022
- Published by Medical University of Lublin in Current Problems of Psychiatry
- Vol. 23 (1) , 35-40
Open AccessSchizo-obsessive disorder - case study
Introduction: Schizo-obsessive disorder is a term that includes a dual diagnosis: schizophrenia and obsessive-compulsive disorder (OCD). The schizo-obsessive disorder definition was made at the end of the 19th century and is still valid today. Nowadays, the coexistence of schizophrenia with obsessive-compulsive syndromes becomes more commonly observed, therefore the recognition and number of the described cases has increased. Material and methods: The aim of this article is to present a clinical case of a patient with a diagnostically and therapeutically difficult disorder, including the comorbidity of schizophrenia and OCD. The analysis of the clinical case and the medical records of a patient and a review of the literature including schizophrenia, OCD, and schizo-obsessive disorder, was performed. Case study: A male patient, 20 years old, single, high school student, who lives with his family. In November 2019 a mental deterioration occurred. Simultaneously, obsessional ideas and behaviors appeared. An ambulatory treatment was introduced, however without adequate response, which was the cause of the first psychiatric hospitalization in 2020. Discussion: Comorbidity between obsessive-compulsive disorder and schizophrenia may cause a particular problem for physicians. Without appropriate diagnosis, there is no possibility to implement proper management and treatment. Obsessive-compulsive symptoms should be treated as relatively common in patients with schizophrenia, which will prevent a mistake in the assessment of the patient’s condition. Conclusions: Due to specific character of the disease, difficulties in diagnosis and treatment, there is a special need for individual therapeutic measures. Appropriate and targeted approach to the patient may be a chance for success in therapy.